Victory Capital Management Inc. Sells 12,912 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Victory Capital Management Inc. reduced its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 66.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,386 shares of the company’s stock after selling 12,912 shares during the quarter. Victory Capital Management Inc. owned approximately 0.07% of Semler Scientific worth $345,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SMLR. Principal Financial Group Inc. purchased a new position in shares of Semler Scientific in the third quarter valued at about $361,000. Verition Fund Management LLC bought a new stake in shares of Semler Scientific in the third quarter worth about $251,000. Geode Capital Management LLC increased its holdings in Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock valued at $3,202,000 after purchasing an additional 12,964 shares during the period. IFP Advisors Inc bought a new position in Semler Scientific during the 4th quarter valued at approximately $54,000. Finally, Jane Street Group LLC lifted its holdings in Semler Scientific by 72.3% in the 3rd quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock worth $400,000 after buying an additional 7,126 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Trading Up 1.0 %

Shares of Semler Scientific stock opened at $39.22 on Friday. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The company has a market cap of $376.39 million, a P/E ratio of 7.99 and a beta of 1.33. The company’s fifty day simple moving average is $47.23 and its two-hundred day simple moving average is $44.21.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $12.41 million for the quarter.

Analyst Ratings Changes

Separately, Lake Street Capital boosted their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.